作者:Lianhong Xu、Lijun Zhang、Robert Jones、Clifford Bryant、Nina Boddeker、Eric Mabery、Gina Bahador、Julia Watson、Jeffery Clough、Murty Arimilli、Wendy Gillette、Dorothy Colagiovanni、Keyu Wang、Craig Gibbs、Choung U. Kim
DOI:10.1016/j.bmcl.2011.01.099
日期:2011.3
There is an urgent need for the development of novel antimicrobial agents that offer effective treatment against MRSA. Using a new class of dipeptide antibiotic TAN-1057A/B as lead, we designed, synthesized and evaluated analogs of TAN-1057A/B. Several novel dihydropyrimidinone antibiotics demonstrating comparable antibiotic efficacy while possessing favorable selectivity were identified. (C) 2011 Elsevier Ltd. All rights reserved.